Characterization of N-methyl-D-aspartate receptors in the hyperammonemic sparse fur mouse

Brain Research

Volumn 797, Issue 2, 1998, Pages 209-217

  Hopkins, Keri J ^a   Oster Granite, Mary Lou ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Neurotoxicity; NMDA receptor; Ornithine carbamoyltransferase deficiency; Quinolinic acid; Sparse fur

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORNITHINE CARBAMOYLTRANSFERASE; QUINOLINIC ACID; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME DEFICIENCY; HYPERAMMONEMIA; LIGAND BINDING; MEMBRANE DEPOLARIZATION; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RECEPTOR UPREGULATION;

AMMONIA; ANIMALS; ANTIBODIES; FEMALE; FRONTAL LOBE; MALE; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; MICROSCOPY, IMMUNOELECTRON; ORNITHINE CARBAMOYLTRANSFERASE; PARIETAL LOBE; PYRAMIDAL CELLS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032578048     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00362-X     Document Type: Article

References (30)

1. Bakker M.H.M., Foster A.C. An investigation of the mechanisms of delayed neuron degeneration caused by direct infection of quinolinic acid into the rat striatum in vivo. Neuroscience. 42:1991;387-395.
2. Batshaw M.L., Robinson M.B., Hyland K., Djali S., Heyes M.P. Quinolinic acid in children with congenital hyperammonemia. Ann. Neurol. 34:1993;676-681.
3. Batshaw M.L., Yudkoff M., McLaughlin B.A., Gorry E., Anegawa N.J., Smith I.A.S., Hyman S.L., Robinson M.B. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency. Gene Ther. 2:1995;743-749.
4. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
5. S.W. Brusilow, A.L. Horwich, Urea cycle enzymes, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Balle (Eds.), The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill Information Services, New York, 1989, pp. 629-663.
6. Ceriotti G. Optimal conditions for ornithine carbamoyltransferase determination. A simple micromethod without deproteinization. Clin. Chem. Acta. 47:1973;97-105.
7. Decavel C., Curras M.C. Increased expression of the N-methyl-D-aspartate receptor subunit, NR1, in immunohistochemically identified mangnocellular hypothalamic neurons during dehydration. Neuroscience. 78:1997;191-202.
8. Del Cerro M.P., Snider R.S., Oster M.L. Subcellular fractions of adult and developing rat cerebellum. Exp. Brain Res. 8:1969;311-320.
9. Doble A. Excitatory amino acid receptors and neurodegeneration. Therapie. 50:1995;319-337.
10. Du F., Williamson J., Bertram E., Lothman E., Okuno E., Schwarcz R. Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells. Neuroscience. 55:1993;975-989.
11. Espey M.G., Chernyshev O.N., Reinhard J.F. Jr., Namboodiri M.A., Colton C.A. Activated human microglia produce the excitotoxin quinolinic acid. NeuroReport. 8:1997;431-434.
12. Giordano M., Ford L.M., Brauckmann J.L., Norman A.B., Sanberg P.R. MK801 prevents quinolinic acid induced behavioral deficits and neurotoxicity in the striatum. Brain Res. Bull. 24:1990;313-319.
13. Gudehithlu K.P., Bhargava H.N. Differential binding of [3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine. Gen. Pharmacol. 27:1996;91-94.
14. Harding B., Leonard J., Erdohazi M. Ornithine carbamoyl transferase deficiency: a neuropathological study. Eur. J. Pediatr. 141:1984;215-220.
15. K.J. Hopkins, J. McKean, R.F. Mervis, M.L. Oster-Granite, Dendritic alterations in cortical pyramidal cells in the sparse fur mouse, in preparation.
16. Jhamandas K.H., Boegman R.J., Beninger R.J. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists. Can. J. Physiol. Pharmacol. 72:1994;1473-1482.
17. Keilhoff G., Wolf G., Stastny F., Schmidt W. Quinolinate neurotoxicity and glutamatergic structures. Neuroscience. 34:1990;235-242.
18. Malcon C., Achaval M., Komlos F., Partata W., Surressing M., Ramirez G., Souza D.O. GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci. Lett. 225:1997;145-148.
19. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
20. Norenberg M.D., Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Arch. Neurol. 33:1979;303-310.
21. Oster Y., Schramm M. Down regulation of NMDA receptor activity by NMDA. Neurosci. Lett. 163:1993;85-88.
22. Ratnakumari L., Qureshi I.A., Butterworth R.F. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem. Biophys. Res. Comm. 184:1992;746-751.
23. Ratnakumari L., Qureshi I.A., Butterworth R.F. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 9:1994;43-51.
24. Ratnakumari L., Qureshi I.A., Butterworth R.F. Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 10:1995;249-255.
25. Resink A., Villa M., Boer G.J., Mohler H., Balazs R. Agonist-induced down-regulation of NMDA receptors in cerebellar granule cells in culture. Eur. J. Neurosci. 7:1995;1700-1706.
26. Robinson M.B., Anegawa N.J., Gorry E., Qureshi I.A., Coyle J.T., Lucki I., Batshaw M.L. Brain serotonin2 and serotonin1A receptors are altered in the congenitally hyperammonemic sparse fur mouse. J. Neurochem. 58:1992;1016-1022.
27. Robinson M.B., Hopkins K.J., Batshaw M.L., McLaughlin B.A., Heyes M.P., Oster-Granite M.L. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Dev. Brain Res. 90:1995;35-44.
28. Sucher N.J., Awobuluyi M., Choi Y.B., Lipton S.A. NMDA receptors: from genes to channels. TiPS. 17:1996;348-355.
29. Topper R., Gehrmann J., Schwarz M., Block F., Noth J., Kreutzberg G.W. Remote microglial activation in the quinolinic acid model of Huntington's disease. Exp. Neurol. 123:1993;271-283.
30. Wise S.P., Jones E.G. Cells of origin and terminal distribution of descending projections of the rat somatic sensory cortex. J. Comp. Neurol. 175:1977;129-158.